nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—ALB—melanoma	0.168	0.512	CbGaD
Clomipramine—ABCB1—melanoma	0.16	0.488	CbGaD
Clomipramine—ALB—Vemurafenib—melanoma	0.0807	0.207	CbGbCtD
Clomipramine—CYP1A2—Carmustine—melanoma	0.0611	0.157	CbGbCtD
Clomipramine—CYP1A2—Vemurafenib—melanoma	0.0483	0.124	CbGbCtD
Clomipramine—CYP3A4—Temozolomide—melanoma	0.0462	0.119	CbGbCtD
Clomipramine—CYP2D6—Vemurafenib—melanoma	0.0398	0.102	CbGbCtD
Clomipramine—CYP1A2—Dacarbazine—melanoma	0.037	0.095	CbGbCtD
Clomipramine—ABCB1—Dactinomycin—melanoma	0.0281	0.072	CbGbCtD
Clomipramine—CYP3A4—Vemurafenib—melanoma	0.0253	0.0649	CbGbCtD
Clomipramine—ABCB1—Docetaxel—melanoma	0.0145	0.0372	CbGbCtD
Clomipramine—CYP3A4—Docetaxel—melanoma	0.00868	0.0223	CbGbCtD
Clomipramine—Clobazam—SLC6A11—melanoma	0.0022	0.462	CrCbGaD
Clomipramine—Olopatadine—S100B—melanoma	0.00137	0.288	CrCbGaD
Clomipramine—GSTP1—hair follicle—melanoma	0.000664	0.0833	CbGeAlD
Clomipramine—HTR2A—hindlimb—melanoma	0.000574	0.072	CbGeAlD
Clomipramine—HTR2A—appendage—melanoma	0.000493	0.0618	CbGeAlD
Clomipramine—GSTP1—neck—melanoma	0.000446	0.0559	CbGeAlD
Clomipramine—HRH2—skin of body—melanoma	0.000401	0.0502	CbGeAlD
Clomipramine—GSTP1—eye—melanoma	0.000332	0.0416	CbGeAlD
Clomipramine—GSTP1—retina—melanoma	0.000329	0.0412	CbGeAlD
Clomipramine—HTR2A—endothelium—melanoma	0.000297	0.0373	CbGeAlD
Clomipramine—GSTP1—skin of body—melanoma	0.000288	0.0362	CbGeAlD
Clomipramine—HTR6—head—melanoma	0.000286	0.0359	CbGeAlD
Clomipramine—HTR2A—blood vessel—melanoma	0.000274	0.0344	CbGeAlD
Clomipramine—GSTP1—mammalian vulva—melanoma	0.000263	0.033	CbGeAlD
Clomipramine—HRH2—head—melanoma	0.000261	0.0328	CbGeAlD
Clomipramine—Flushing—Temozolomide—melanoma	0.000247	0.00152	CcSEcCtD
Clomipramine—Cardiac disorder—Temozolomide—melanoma	0.000247	0.00152	CcSEcCtD
Clomipramine—Arrhythmia—Carmustine—melanoma	0.000246	0.00151	CcSEcCtD
Clomipramine—Leukopenia—Bleomycin—melanoma	0.000245	0.00151	CcSEcCtD
Clomipramine—Dizziness—Vemurafenib—melanoma	0.000244	0.0015	CcSEcCtD
Clomipramine—Alopecia—Carmustine—melanoma	0.000243	0.0015	CcSEcCtD
Clomipramine—Angiopathy—Temozolomide—melanoma	0.000241	0.00148	CcSEcCtD
Clomipramine—Mental disorder—Carmustine—melanoma	0.000241	0.00148	CcSEcCtD
Clomipramine—Ataxia—Docetaxel—melanoma	0.00024	0.00148	CcSEcCtD
Clomipramine—Immune system disorder—Temozolomide—melanoma	0.00024	0.00148	CcSEcCtD
Clomipramine—Mediastinal disorder—Temozolomide—melanoma	0.000239	0.00147	CcSEcCtD
Clomipramine—Malnutrition—Carmustine—melanoma	0.000239	0.00147	CcSEcCtD
Clomipramine—Cough—Bleomycin—melanoma	0.000239	0.00147	CcSEcCtD
Clomipramine—Chills—Temozolomide—melanoma	0.000238	0.00147	CcSEcCtD
Clomipramine—HTR2B—skin of body—melanoma	0.000238	0.0298	CbGeAlD
Clomipramine—Dehydration—Docetaxel—melanoma	0.000237	0.00146	CcSEcCtD
Clomipramine—Ill-defined disorder—Dactinomycin—melanoma	0.000237	0.00146	CcSEcCtD
Clomipramine—Anaemia—Dactinomycin—melanoma	0.000236	0.00145	CcSEcCtD
Clomipramine—Vomiting—Vemurafenib—melanoma	0.000235	0.00145	CcSEcCtD
Clomipramine—Alopecia—Temozolomide—melanoma	0.000235	0.00145	CcSEcCtD
Clomipramine—Dry skin—Docetaxel—melanoma	0.000234	0.00144	CcSEcCtD
Clomipramine—Myalgia—Bleomycin—melanoma	0.000233	0.00144	CcSEcCtD
Clomipramine—Chest pain—Bleomycin—melanoma	0.000233	0.00144	CcSEcCtD
Clomipramine—Orthostatic hypotension—Docetaxel—melanoma	0.000233	0.00144	CcSEcCtD
Clomipramine—Rash—Vemurafenib—melanoma	0.000233	0.00143	CcSEcCtD
Clomipramine—Mental disorder—Temozolomide—melanoma	0.000233	0.00143	CcSEcCtD
Clomipramine—Dermatitis—Vemurafenib—melanoma	0.000233	0.00143	CcSEcCtD
Clomipramine—Back pain—Carmustine—melanoma	0.000231	0.00143	CcSEcCtD
Clomipramine—Headache—Vemurafenib—melanoma	0.000231	0.00142	CcSEcCtD
Clomipramine—Malnutrition—Temozolomide—melanoma	0.000231	0.00142	CcSEcCtD
Clomipramine—Breast disorder—Docetaxel—melanoma	0.000231	0.00142	CcSEcCtD
Clomipramine—Discomfort—Bleomycin—melanoma	0.000231	0.00142	CcSEcCtD
Clomipramine—Malaise—Dactinomycin—melanoma	0.000231	0.00142	CcSEcCtD
Clomipramine—Leukopenia—Dactinomycin—melanoma	0.000229	0.00141	CcSEcCtD
Clomipramine—Dysgeusia—Temozolomide—melanoma	0.000226	0.00139	CcSEcCtD
Clomipramine—Confusional state—Bleomycin—melanoma	0.000226	0.00139	CcSEcCtD
Clomipramine—Vision blurred—Carmustine—melanoma	0.000226	0.00139	CcSEcCtD
Clomipramine—Tremor—Carmustine—melanoma	0.000224	0.00138	CcSEcCtD
Clomipramine—Anaphylactic shock—Bleomycin—melanoma	0.000224	0.00138	CcSEcCtD
Clomipramine—Oedema—Bleomycin—melanoma	0.000224	0.00138	CcSEcCtD
Clomipramine—Back pain—Temozolomide—melanoma	0.000224	0.00138	CcSEcCtD
Clomipramine—Anaemia—Carmustine—melanoma	0.000221	0.00136	CcSEcCtD
Clomipramine—Dysphagia—Docetaxel—melanoma	0.000221	0.00136	CcSEcCtD
Clomipramine—Agitation—Carmustine—melanoma	0.00022	0.00135	CcSEcCtD
Clomipramine—Nausea—Vemurafenib—melanoma	0.000219	0.00135	CcSEcCtD
Clomipramine—Thrombocytopenia—Bleomycin—melanoma	0.000219	0.00135	CcSEcCtD
Clomipramine—Vision blurred—Temozolomide—melanoma	0.000218	0.00134	CcSEcCtD
Clomipramine—Myalgia—Dactinomycin—melanoma	0.000218	0.00134	CcSEcCtD
Clomipramine—Bronchospasm—Docetaxel—melanoma	0.000217	0.00134	CcSEcCtD
Clomipramine—Tremor—Temozolomide—melanoma	0.000217	0.00133	CcSEcCtD
Clomipramine—Discomfort—Dactinomycin—melanoma	0.000215	0.00132	CcSEcCtD
Clomipramine—Ill-defined disorder—Temozolomide—melanoma	0.000215	0.00132	CcSEcCtD
Clomipramine—Leukopenia—Carmustine—melanoma	0.000214	0.00132	CcSEcCtD
Clomipramine—Anaemia—Temozolomide—melanoma	0.000214	0.00132	CcSEcCtD
Clomipramine—Anorexia—Bleomycin—melanoma	0.000213	0.00131	CcSEcCtD
Clomipramine—Agitation—Temozolomide—melanoma	0.000213	0.00131	CcSEcCtD
Clomipramine—Pancytopenia—Docetaxel—melanoma	0.00021	0.00129	CcSEcCtD
Clomipramine—Hypotension—Bleomycin—melanoma	0.000209	0.00129	CcSEcCtD
Clomipramine—Oedema—Dactinomycin—melanoma	0.000209	0.00128	CcSEcCtD
Clomipramine—Malaise—Temozolomide—melanoma	0.000209	0.00128	CcSEcCtD
Clomipramine—Vertigo—Temozolomide—melanoma	0.000208	0.00128	CcSEcCtD
Clomipramine—Convulsion—Carmustine—melanoma	0.000207	0.00128	CcSEcCtD
Clomipramine—Leukopenia—Temozolomide—melanoma	0.000207	0.00127	CcSEcCtD
Clomipramine—Hypertension—Carmustine—melanoma	0.000207	0.00127	CcSEcCtD
Clomipramine—Palpitations—Temozolomide—melanoma	0.000204	0.00126	CcSEcCtD
Clomipramine—Thrombocytopenia—Dactinomycin—melanoma	0.000204	0.00126	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000204	0.00126	CcSEcCtD
Clomipramine—Chest pain—Carmustine—melanoma	0.000204	0.00125	CcSEcCtD
Clomipramine—Myalgia—Carmustine—melanoma	0.000204	0.00125	CcSEcCtD
Clomipramine—Anxiety—Carmustine—melanoma	0.000203	0.00125	CcSEcCtD
Clomipramine—Cough—Temozolomide—melanoma	0.000202	0.00124	CcSEcCtD
Clomipramine—Paraesthesia—Bleomycin—melanoma	0.000201	0.00124	CcSEcCtD
Clomipramine—Weight increased—Docetaxel—melanoma	0.000201	0.00124	CcSEcCtD
Clomipramine—Convulsion—Temozolomide—melanoma	0.0002	0.00123	CcSEcCtD
Clomipramine—Weight decreased—Docetaxel—melanoma	0.0002	0.00123	CcSEcCtD
Clomipramine—Hypertension—Temozolomide—melanoma	0.0002	0.00123	CcSEcCtD
Clomipramine—Dyspnoea—Bleomycin—melanoma	0.000199	0.00123	CcSEcCtD
Clomipramine—Anorexia—Dactinomycin—melanoma	0.000199	0.00122	CcSEcCtD
Clomipramine—Pneumonia—Docetaxel—melanoma	0.000198	0.00122	CcSEcCtD
Clomipramine—Confusional state—Carmustine—melanoma	0.000197	0.00121	CcSEcCtD
Clomipramine—Myalgia—Temozolomide—melanoma	0.000197	0.00121	CcSEcCtD
Clomipramine—Arthralgia—Temozolomide—melanoma	0.000197	0.00121	CcSEcCtD
Clomipramine—HTR2A—neck—melanoma	0.000196	0.0246	CbGeAlD
Clomipramine—Anxiety—Temozolomide—melanoma	0.000196	0.00121	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000196	0.0012	CcSEcCtD
Clomipramine—Oedema—Carmustine—melanoma	0.000195	0.0012	CcSEcCtD
Clomipramine—Discomfort—Temozolomide—melanoma	0.000195	0.0012	CcSEcCtD
Clomipramine—Decreased appetite—Bleomycin—melanoma	0.000195	0.0012	CcSEcCtD
Clomipramine—Acute coronary syndrome—Docetaxel—melanoma	0.000194	0.00119	CcSEcCtD
Clomipramine—Myocardial infarction—Docetaxel—melanoma	0.000193	0.00119	CcSEcCtD
Clomipramine—Neuropathy peripheral—Docetaxel—melanoma	0.000193	0.00119	CcSEcCtD
Clomipramine—Dry mouth—Temozolomide—melanoma	0.000193	0.00119	CcSEcCtD
Clomipramine—Jaundice—Docetaxel—melanoma	0.000192	0.00118	CcSEcCtD
Clomipramine—Pain—Bleomycin—melanoma	0.000191	0.00118	CcSEcCtD
Clomipramine—Conjunctivitis—Docetaxel—melanoma	0.000191	0.00118	CcSEcCtD
Clomipramine—Thrombocytopenia—Carmustine—melanoma	0.000191	0.00118	CcSEcCtD
Clomipramine—Tachycardia—Carmustine—melanoma	0.000191	0.00117	CcSEcCtD
Clomipramine—Confusional state—Temozolomide—melanoma	0.00019	0.00117	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00019	0.00117	CcSEcCtD
Clomipramine—Anaphylactic shock—Temozolomide—melanoma	0.000189	0.00116	CcSEcCtD
Clomipramine—Oedema—Temozolomide—melanoma	0.000189	0.00116	CcSEcCtD
Clomipramine—GSTP1—head—melanoma	0.000188	0.0236	CbGeAlD
Clomipramine—Anorexia—Carmustine—melanoma	0.000186	0.00115	CcSEcCtD
Clomipramine—Hepatobiliary disease—Docetaxel—melanoma	0.000186	0.00115	CcSEcCtD
Clomipramine—Epistaxis—Docetaxel—melanoma	0.000186	0.00114	CcSEcCtD
Clomipramine—Nervous system disorder—Temozolomide—melanoma	0.000185	0.00114	CcSEcCtD
Clomipramine—Thrombocytopenia—Temozolomide—melanoma	0.000185	0.00114	CcSEcCtD
Clomipramine—Feeling abnormal—Bleomycin—melanoma	0.000184	0.00114	CcSEcCtD
Clomipramine—Agranulocytosis—Docetaxel—melanoma	0.000184	0.00113	CcSEcCtD
Clomipramine—Skin disorder—Temozolomide—melanoma	0.000183	0.00113	CcSEcCtD
Clomipramine—HRH2—lymph node—melanoma	0.000183	0.023	CbGeAlD
Clomipramine—Hypotension—Carmustine—melanoma	0.000183	0.00112	CcSEcCtD
Clomipramine—Hyperhidrosis—Temozolomide—melanoma	0.000182	0.00112	CcSEcCtD
Clomipramine—Decreased appetite—Dactinomycin—melanoma	0.000181	0.00112	CcSEcCtD
Clomipramine—Fatigue—Dactinomycin—melanoma	0.00018	0.00111	CcSEcCtD
Clomipramine—Anorexia—Temozolomide—melanoma	0.00018	0.00111	CcSEcCtD
Clomipramine—ABCB1—blood vessel—melanoma	0.00018	0.0225	CbGeAlD
Clomipramine—Pain—Dactinomycin—melanoma	0.000178	0.0011	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Carmustine—melanoma	0.000178	0.0011	CcSEcCtD
Clomipramine—Urticaria—Bleomycin—melanoma	0.000178	0.00109	CcSEcCtD
Clomipramine—Rhinitis—Docetaxel—melanoma	0.000177	0.00109	CcSEcCtD
Clomipramine—Body temperature increased—Bleomycin—melanoma	0.000177	0.00109	CcSEcCtD
Clomipramine—Hepatitis—Docetaxel—melanoma	0.000177	0.00109	CcSEcCtD
Clomipramine—Insomnia—Carmustine—melanoma	0.000177	0.00109	CcSEcCtD
Clomipramine—Hypoaesthesia—Docetaxel—melanoma	0.000176	0.00108	CcSEcCtD
Clomipramine—Paraesthesia—Carmustine—melanoma	0.000175	0.00108	CcSEcCtD
Clomipramine—Pharyngitis—Docetaxel—melanoma	0.000175	0.00108	CcSEcCtD
Clomipramine—Urinary tract disorder—Docetaxel—melanoma	0.000174	0.00107	CcSEcCtD
Clomipramine—Dyspnoea—Carmustine—melanoma	0.000174	0.00107	CcSEcCtD
Clomipramine—Somnolence—Carmustine—melanoma	0.000174	0.00107	CcSEcCtD
Clomipramine—Connective tissue disorder—Docetaxel—melanoma	0.000174	0.00107	CcSEcCtD
Clomipramine—Urethral disorder—Docetaxel—melanoma	0.000173	0.00107	CcSEcCtD
Clomipramine—Feeling abnormal—Dactinomycin—melanoma	0.000172	0.00106	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000172	0.00106	CcSEcCtD
Clomipramine—Insomnia—Temozolomide—melanoma	0.000171	0.00105	CcSEcCtD
Clomipramine—Gastrointestinal pain—Dactinomycin—melanoma	0.000171	0.00105	CcSEcCtD
Clomipramine—Visual impairment—Docetaxel—melanoma	0.00017	0.00105	CcSEcCtD
Clomipramine—Decreased appetite—Carmustine—melanoma	0.00017	0.00105	CcSEcCtD
Clomipramine—Paraesthesia—Temozolomide—melanoma	0.000169	0.00104	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Carmustine—melanoma	0.000169	0.00104	CcSEcCtD
Clomipramine—Dyspnoea—Temozolomide—melanoma	0.000168	0.00104	CcSEcCtD
Clomipramine—Somnolence—Temozolomide—melanoma	0.000168	0.00103	CcSEcCtD
Clomipramine—Pain—Carmustine—melanoma	0.000167	0.00103	CcSEcCtD
Clomipramine—Constipation—Carmustine—melanoma	0.000167	0.00103	CcSEcCtD
Clomipramine—Dyspepsia—Temozolomide—melanoma	0.000166	0.00102	CcSEcCtD
Clomipramine—HTR2C—head—melanoma	0.000165	0.0207	CbGeAlD
Clomipramine—Eye disorder—Docetaxel—melanoma	0.000165	0.00102	CcSEcCtD
Clomipramine—Abdominal pain—Dactinomycin—melanoma	0.000165	0.00102	CcSEcCtD
Clomipramine—Body temperature increased—Dactinomycin—melanoma	0.000165	0.00102	CcSEcCtD
Clomipramine—Hypersensitivity—Bleomycin—melanoma	0.000165	0.00101	CcSEcCtD
Clomipramine—Decreased appetite—Temozolomide—melanoma	0.000164	0.00101	CcSEcCtD
Clomipramine—Cardiac disorder—Docetaxel—melanoma	0.000164	0.00101	CcSEcCtD
Clomipramine—Flushing—Docetaxel—melanoma	0.000164	0.00101	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Temozolomide—melanoma	0.000163	0.001	CcSEcCtD
Clomipramine—Fatigue—Temozolomide—melanoma	0.000163	0.001	CcSEcCtD
Clomipramine—Pain—Temozolomide—melanoma	0.000161	0.000994	CcSEcCtD
Clomipramine—Constipation—Temozolomide—melanoma	0.000161	0.000994	CcSEcCtD
Clomipramine—Feeling abnormal—Carmustine—melanoma	0.000161	0.000991	CcSEcCtD
Clomipramine—Asthenia—Bleomycin—melanoma	0.000161	0.000988	CcSEcCtD
Clomipramine—Angiopathy—Docetaxel—melanoma	0.00016	0.000987	CcSEcCtD
Clomipramine—Gastrointestinal pain—Carmustine—melanoma	0.00016	0.000983	CcSEcCtD
Clomipramine—Immune system disorder—Docetaxel—melanoma	0.00016	0.000982	CcSEcCtD
Clomipramine—Mediastinal disorder—Docetaxel—melanoma	0.000159	0.00098	CcSEcCtD
Clomipramine—Chills—Docetaxel—melanoma	0.000159	0.000976	CcSEcCtD
Clomipramine—Pruritus—Bleomycin—melanoma	0.000158	0.000975	CcSEcCtD
Clomipramine—Arrhythmia—Docetaxel—melanoma	0.000158	0.000972	CcSEcCtD
Clomipramine—SLC6A4—head—melanoma	0.000157	0.0196	CbGeAlD
Clomipramine—Alopecia—Docetaxel—melanoma	0.000156	0.000961	CcSEcCtD
Clomipramine—Feeling abnormal—Temozolomide—melanoma	0.000156	0.000958	CcSEcCtD
Clomipramine—HTR2B—head—melanoma	0.000155	0.0195	CbGeAlD
Clomipramine—Mental disorder—Docetaxel—melanoma	0.000155	0.000953	CcSEcCtD
Clomipramine—Body temperature increased—Carmustine—melanoma	0.000154	0.000951	CcSEcCtD
Clomipramine—Abdominal pain—Carmustine—melanoma	0.000154	0.000951	CcSEcCtD
Clomipramine—Gastrointestinal pain—Temozolomide—melanoma	0.000154	0.00095	CcSEcCtD
Clomipramine—Malnutrition—Docetaxel—melanoma	0.000154	0.000947	CcSEcCtD
Clomipramine—Hypersensitivity—Dactinomycin—melanoma	0.000154	0.000947	CcSEcCtD
Clomipramine—Dysgeusia—Docetaxel—melanoma	0.000151	0.000927	CcSEcCtD
Clomipramine—Urticaria—Temozolomide—melanoma	0.00015	0.000923	CcSEcCtD
Clomipramine—Asthenia—Dactinomycin—melanoma	0.00015	0.000922	CcSEcCtD
Clomipramine—Abdominal pain—Temozolomide—melanoma	0.000149	0.000919	CcSEcCtD
Clomipramine—Body temperature increased—Temozolomide—melanoma	0.000149	0.000919	CcSEcCtD
Clomipramine—Back pain—Docetaxel—melanoma	0.000149	0.000916	CcSEcCtD
Clomipramine—Muscle spasms—Docetaxel—melanoma	0.000148	0.00091	CcSEcCtD
Clomipramine—HTR2A—eye—melanoma	0.000146	0.0183	CbGeAlD
Clomipramine—HTR2A—retina—melanoma	0.000145	0.0181	CbGeAlD
Clomipramine—Hypersensitivity—Carmustine—melanoma	0.000144	0.000886	CcSEcCtD
Clomipramine—Diarrhoea—Dactinomycin—melanoma	0.000143	0.000879	CcSEcCtD
Clomipramine—Vomiting—Bleomycin—melanoma	0.000142	0.000876	CcSEcCtD
Clomipramine—Anaemia—Docetaxel—melanoma	0.000142	0.000875	CcSEcCtD
Clomipramine—Rash—Bleomycin—melanoma	0.000141	0.000869	CcSEcCtD
Clomipramine—Dermatitis—Bleomycin—melanoma	0.000141	0.000868	CcSEcCtD
Clomipramine—Asthenia—Carmustine—melanoma	0.00014	0.000863	CcSEcCtD
Clomipramine—Hypersensitivity—Temozolomide—melanoma	0.000139	0.000856	CcSEcCtD
Clomipramine—Syncope—Docetaxel—melanoma	0.000138	0.000849	CcSEcCtD
Clomipramine—SLC6A2—head—melanoma	0.000138	0.0173	CbGeAlD
Clomipramine—Leukopenia—Docetaxel—melanoma	0.000138	0.000848	CcSEcCtD
Clomipramine—ADRA2A—mammalian vulva—melanoma	0.000136	0.0171	CbGeAlD
Clomipramine—Palpitations—Docetaxel—melanoma	0.000136	0.000837	CcSEcCtD
Clomipramine—Asthenia—Temozolomide—melanoma	0.000135	0.000834	CcSEcCtD
Clomipramine—Loss of consciousness—Docetaxel—melanoma	0.000135	0.000832	CcSEcCtD
Clomipramine—Cough—Docetaxel—melanoma	0.000134	0.000826	CcSEcCtD
Clomipramine—Diarrhoea—Carmustine—melanoma	0.000134	0.000823	CcSEcCtD
Clomipramine—Pruritus—Temozolomide—melanoma	0.000134	0.000822	CcSEcCtD
Clomipramine—Convulsion—Docetaxel—melanoma	0.000133	0.00082	CcSEcCtD
Clomipramine—Nausea—Bleomycin—melanoma	0.000133	0.000818	CcSEcCtD
Clomipramine—Hypertension—Docetaxel—melanoma	0.000133	0.000817	CcSEcCtD
Clomipramine—Vomiting—Dactinomycin—melanoma	0.000133	0.000817	CcSEcCtD
Clomipramine—GSTP1—lymph node—melanoma	0.000132	0.0165	CbGeAlD
Clomipramine—Rash—Dactinomycin—melanoma	0.000132	0.00081	CcSEcCtD
Clomipramine—Arthralgia—Docetaxel—melanoma	0.000131	0.000806	CcSEcCtD
Clomipramine—Chest pain—Docetaxel—melanoma	0.000131	0.000806	CcSEcCtD
Clomipramine—Myalgia—Docetaxel—melanoma	0.000131	0.000806	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00013	0.000801	CcSEcCtD
Clomipramine—Dizziness—Carmustine—melanoma	0.000129	0.000795	CcSEcCtD
Clomipramine—Diarrhoea—Temozolomide—melanoma	0.000129	0.000795	CcSEcCtD
Clomipramine—Dry mouth—Docetaxel—melanoma	0.000128	0.000788	CcSEcCtD
Clomipramine—Confusional state—Docetaxel—melanoma	0.000127	0.000779	CcSEcCtD
Clomipramine—Anaphylactic shock—Docetaxel—melanoma	0.000126	0.000773	CcSEcCtD
Clomipramine—Oedema—Docetaxel—melanoma	0.000126	0.000773	CcSEcCtD
Clomipramine—Dizziness—Temozolomide—melanoma	0.000125	0.000768	CcSEcCtD
Clomipramine—Vomiting—Carmustine—melanoma	0.000124	0.000765	CcSEcCtD
Clomipramine—Nausea—Dactinomycin—melanoma	0.000124	0.000763	CcSEcCtD
Clomipramine—Shock—Docetaxel—melanoma	0.000123	0.00076	CcSEcCtD
Clomipramine—Rash—Carmustine—melanoma	0.000123	0.000758	CcSEcCtD
Clomipramine—Nervous system disorder—Docetaxel—melanoma	0.000123	0.000758	CcSEcCtD
Clomipramine—Dermatitis—Carmustine—melanoma	0.000123	0.000757	CcSEcCtD
Clomipramine—Thrombocytopenia—Docetaxel—melanoma	0.000123	0.000757	CcSEcCtD
Clomipramine—Tachycardia—Docetaxel—melanoma	0.000123	0.000754	CcSEcCtD
Clomipramine—Headache—Carmustine—melanoma	0.000122	0.000753	CcSEcCtD
Clomipramine—Skin disorder—Docetaxel—melanoma	0.000122	0.000751	CcSEcCtD
Clomipramine—Vomiting—Temozolomide—melanoma	0.00012	0.000739	CcSEcCtD
Clomipramine—Anorexia—Docetaxel—melanoma	0.00012	0.000737	CcSEcCtD
Clomipramine—Rash—Temozolomide—melanoma	0.000119	0.000733	CcSEcCtD
Clomipramine—Dermatitis—Temozolomide—melanoma	0.000119	0.000732	CcSEcCtD
Clomipramine—Headache—Temozolomide—melanoma	0.000118	0.000728	CcSEcCtD
Clomipramine—Hypotension—Docetaxel—melanoma	0.000117	0.000722	CcSEcCtD
Clomipramine—Nausea—Carmustine—melanoma	0.000116	0.000714	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000114	0.000704	CcSEcCtD
Clomipramine—Insomnia—Docetaxel—melanoma	0.000114	0.000699	CcSEcCtD
Clomipramine—ALB—lymph node—melanoma	0.000113	0.0142	CbGeAlD
Clomipramine—Paraesthesia—Docetaxel—melanoma	0.000113	0.000694	CcSEcCtD
Clomipramine—Nausea—Temozolomide—melanoma	0.000112	0.00069	CcSEcCtD
Clomipramine—Dyspnoea—Docetaxel—melanoma	0.000112	0.000689	CcSEcCtD
Clomipramine—Somnolence—Docetaxel—melanoma	0.000112	0.000687	CcSEcCtD
Clomipramine—Dyspepsia—Docetaxel—melanoma	0.00011	0.00068	CcSEcCtD
Clomipramine—Decreased appetite—Docetaxel—melanoma	0.000109	0.000672	CcSEcCtD
Clomipramine—HTR2B—lymph node—melanoma	0.000109	0.0136	CbGeAlD
Clomipramine—Gastrointestinal disorder—Docetaxel—melanoma	0.000108	0.000667	CcSEcCtD
Clomipramine—Fatigue—Docetaxel—melanoma	0.000108	0.000666	CcSEcCtD
Clomipramine—Pain—Docetaxel—melanoma	0.000107	0.000661	CcSEcCtD
Clomipramine—Constipation—Docetaxel—melanoma	0.000107	0.000661	CcSEcCtD
Clomipramine—Feeling abnormal—Docetaxel—melanoma	0.000103	0.000637	CcSEcCtD
Clomipramine—Gastrointestinal pain—Docetaxel—melanoma	0.000103	0.000632	CcSEcCtD
Clomipramine—Abdominal pain—Docetaxel—melanoma	9.92e-05	0.000611	CcSEcCtD
Clomipramine—Body temperature increased—Docetaxel—melanoma	9.92e-05	0.000611	CcSEcCtD
Clomipramine—ADRA2A—head—melanoma	9.75e-05	0.0122	CbGeAlD
Clomipramine—SLC6A2—lymph node—melanoma	9.65e-05	0.0121	CbGeAlD
Clomipramine—ABCB1—retina—melanoma	9.48e-05	0.0119	CbGeAlD
Clomipramine—Hypersensitivity—Docetaxel—melanoma	9.25e-05	0.000569	CcSEcCtD
Clomipramine—Asthenia—Docetaxel—melanoma	9.01e-05	0.000554	CcSEcCtD
Clomipramine—Triflupromazine—ABCB1—melanoma	8.9e-05	0.0187	CrCbGaD
Clomipramine—Pruritus—Docetaxel—melanoma	8.88e-05	0.000547	CcSEcCtD
Clomipramine—Acepromazine—ALB—melanoma	8.63e-05	0.0181	CrCbGaD
Clomipramine—Diarrhoea—Docetaxel—melanoma	8.59e-05	0.000529	CcSEcCtD
Clomipramine—Thioproperazine—ALB—melanoma	8.43e-05	0.0177	CrCbGaD
Clomipramine—Dizziness—Docetaxel—melanoma	8.3e-05	0.000511	CcSEcCtD
Clomipramine—Pipotiazine—ALB—melanoma	8.3e-05	0.0174	CrCbGaD
Clomipramine—HTR2A—head—melanoma	8.29e-05	0.0104	CbGeAlD
Clomipramine—Vomiting—Docetaxel—melanoma	7.98e-05	0.000491	CcSEcCtD
Clomipramine—Clobazam—ABCB1—melanoma	7.92e-05	0.0166	CrCbGaD
Clomipramine—Rash—Docetaxel—melanoma	7.91e-05	0.000487	CcSEcCtD
Clomipramine—Dermatitis—Docetaxel—melanoma	7.91e-05	0.000487	CcSEcCtD
Clomipramine—Headache—Docetaxel—melanoma	7.86e-05	0.000484	CcSEcCtD
Clomipramine—ABCB1—mammalian vulva—melanoma	7.59e-05	0.00952	CbGeAlD
Clomipramine—CYP2D6—head—melanoma	7.55e-05	0.00947	CbGeAlD
Clomipramine—Nausea—Docetaxel—melanoma	7.46e-05	0.000459	CcSEcCtD
Clomipramine—ADRA2A—lymph node—melanoma	6.82e-05	0.00856	CbGeAlD
Clomipramine—Nortriptyline—ALB—melanoma	6.41e-05	0.0134	CrCbGaD
Clomipramine—Chlorprothixene—ABCB1—melanoma	6.23e-05	0.0131	CrCbGaD
Clomipramine—Flurazepam—ABCB1—melanoma	5.82e-05	0.0122	CrCbGaD
Clomipramine—Trimipramine—ABCB1—melanoma	5.76e-05	0.0121	CrCbGaD
Clomipramine—Promethazine—ABCB1—melanoma	5.54e-05	0.0116	CrCbGaD
Clomipramine—Doxepin—ABCB1—melanoma	5.49e-05	0.0115	CrCbGaD
Clomipramine—Trifluoperazine—ABCB1—melanoma	5.47e-05	0.0115	CrCbGaD
Clomipramine—ABCB1—head—melanoma	5.43e-05	0.00681	CbGeAlD
Clomipramine—Desipramine—ABCB1—melanoma	5.03e-05	0.0106	CrCbGaD
Clomipramine—Diazepam—ALB—melanoma	4.84e-05	0.0102	CrCbGaD
Clomipramine—Diazepam—ABCB1—melanoma	4.62e-05	0.0097	CrCbGaD
Clomipramine—Chlorpromazine—ALB—melanoma	4.5e-05	0.00944	CrCbGaD
Clomipramine—Amitriptyline—ALB—melanoma	4.45e-05	0.00933	CrCbGaD
Clomipramine—Chlorpromazine—ABCB1—melanoma	4.29e-05	0.00901	CrCbGaD
Clomipramine—Imipramine—ABCB1—melanoma	4.27e-05	0.00896	CrCbGaD
Clomipramine—Amitriptyline—ABCB1—melanoma	4.24e-05	0.00891	CrCbGaD
Clomipramine—ABCB1—lymph node—melanoma	3.8e-05	0.00477	CbGeAlD
Clomipramine—ALB—Hemostasis—PIK3CA—melanoma	5.23e-06	4.89e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—EGF—melanoma	5.23e-06	4.88e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—KDR—melanoma	5.22e-06	4.88e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PRKCA—melanoma	5.2e-06	4.86e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ABCB1—melanoma	5.2e-06	4.86e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CCND1—melanoma	5.18e-06	4.84e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ERCC2—melanoma	5.16e-06	4.82e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CTNNB1—melanoma	5.13e-06	4.79e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—FGF2—melanoma	5.13e-06	4.79e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PRKCA—melanoma	5.08e-06	4.75e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—MAPK3—melanoma	5.06e-06	4.73e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—TP53—melanoma	5.06e-06	4.73e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PIK3CD—melanoma	5.06e-06	4.73e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ERCC2—melanoma	5.04e-06	4.71e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—PIK3CA—melanoma	5.04e-06	4.71e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MMP9—melanoma	5.03e-06	4.7e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—FN1—melanoma	5.03e-06	4.7e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CDKN1A—melanoma	5.01e-06	4.68e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PTEN—melanoma	5e-06	4.67e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—ALB—melanoma	4.99e-06	4.67e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—NFKB1—melanoma	4.97e-06	4.65e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—BRAF—melanoma	4.97e-06	4.64e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—VEGFA—melanoma	4.95e-06	4.62e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NOTCH1—melanoma	4.92e-06	4.6e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP17A1—melanoma	4.91e-06	4.58e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—STAT3—melanoma	4.9e-06	4.58e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—NRAS—melanoma	4.89e-06	4.56e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—AKT1—melanoma	4.88e-06	4.56e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TP53—melanoma	4.87e-06	4.55e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IGF1—melanoma	4.84e-06	4.52e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—HRAS—melanoma	4.84e-06	4.52e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CD80—melanoma	4.82e-06	4.5e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—MAPK1—melanoma	4.82e-06	4.5e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—EGFR—melanoma	4.82e-06	4.5e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—PIK3CA—melanoma	4.82e-06	4.5e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—APC—melanoma	4.81e-06	4.5e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PIK3CG—melanoma	4.81e-06	4.5e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—KIT—melanoma	4.81e-06	4.5e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—NRAS—melanoma	4.81e-06	4.5e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MDM2—melanoma	4.8e-06	4.48e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PRKCA—melanoma	4.79e-06	4.47e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.76e-06	4.45e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—EGF—melanoma	4.76e-06	4.44e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ERCC2—melanoma	4.75e-06	4.44e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—ERBB2—melanoma	4.73e-06	4.42e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.72e-06	4.41e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MAP2K1—melanoma	4.68e-06	4.37e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MAPK3—melanoma	4.68e-06	4.37e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PIK3CB—melanoma	4.67e-06	4.36e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—HRAS—melanoma	4.66e-06	4.35e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PIK3CD—melanoma	4.65e-06	4.34e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GNA11—melanoma	4.63e-06	4.33e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—MAPK3—melanoma	4.61e-06	4.31e-05	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—PIK3CA—melanoma	4.61e-06	4.3e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—KRAS—melanoma	4.55e-06	4.25e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MYC—melanoma	4.55e-06	4.25e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PIK3CG—melanoma	4.54e-06	4.24e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—FASN—melanoma	4.53e-06	4.24e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—BRAF—melanoma	4.52e-06	4.23e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—VEGFA—melanoma	4.51e-06	4.22e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CXCL8—melanoma	4.48e-06	4.19e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—STAT3—melanoma	4.47e-06	4.18e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IL6—melanoma	4.46e-06	4.17e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—SLC5A5—melanoma	4.46e-06	4.17e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—NRAS—melanoma	4.46e-06	4.17e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—HRAS—melanoma	4.46e-06	4.16e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MAPK1—melanoma	4.45e-06	4.16e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—FGF2—melanoma	4.45e-06	4.16e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—EGFR—melanoma	4.45e-06	4.16e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PIK3CB—melanoma	4.41e-06	4.12e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ABCB1—melanoma	4.41e-06	4.12e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IGF1—melanoma	4.41e-06	4.12e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—MAPK1—melanoma	4.38e-06	4.1e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—EGFR—melanoma	4.38e-06	4.1e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PPARG—melanoma	4.38e-06	4.1e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CDKN1B—melanoma	4.38e-06	4.09e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PTGS2—melanoma	4.37e-06	4.08e-05	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—AKT1—melanoma	4.33e-06	4.05e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CD44—melanoma	4.31e-06	4.02e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GNAQ—melanoma	4.31e-06	4.02e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CASP3—melanoma	4.29e-06	4.01e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL2—melanoma	4.29e-06	4e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.28e-06	4e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—AKT1—melanoma	4.27e-06	3.99e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MAPK3—melanoma	4.27e-06	3.99e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—IL6—melanoma	4.26e-06	3.98e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MAP2K1—melanoma	4.26e-06	3.98e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PIK3CD—melanoma	4.23e-06	3.95e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—KRAS—melanoma	4.2e-06	3.93e-05	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—PIK3CA—melanoma	4.19e-06	3.91e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—PIK3CA—melanoma	4.18e-06	3.91e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CCND1—melanoma	4.18e-06	3.9e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MDM2—melanoma	4.17e-06	3.89e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MYC—melanoma	4.15e-06	3.88e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—KRAS—melanoma	4.14e-06	3.87e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CTNNB1—melanoma	4.14e-06	3.87e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP1B1—melanoma	4.13e-06	3.86e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—AKT1—melanoma	4.11e-06	3.84e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ERBB2—melanoma	4.11e-06	3.84e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PIK3CG—melanoma	4.08e-06	3.81e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MAPK1—melanoma	4.06e-06	3.8e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—EGFR—melanoma	4.06e-06	3.8e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MMP9—melanoma	4.06e-06	3.79e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PRKCA—melanoma	4.06e-06	3.79e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PIK3CB—melanoma	4.05e-06	3.79e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—FGF2—melanoma	4.05e-06	3.78e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CDKN1A—melanoma	4.04e-06	3.78e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PTEN—melanoma	4.03e-06	3.77e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ERCC2—melanoma	4.02e-06	3.76e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NFKB1—melanoma	4.01e-06	3.75e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PIK3CD—melanoma	3.99e-06	3.73e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PIK3CG—melanoma	3.98e-06	3.72e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PPARG—melanoma	3.93e-06	3.68e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—AKT1—melanoma	3.93e-06	3.68e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CXCL8—melanoma	3.89e-06	3.64e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—HRAS—melanoma	3.87e-06	3.62e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—PIK3CA—melanoma	3.86e-06	3.61e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PPARG—melanoma	3.84e-06	3.59e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—KRAS—melanoma	3.84e-06	3.59e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PTEN—melanoma	3.81e-06	3.56e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—PIK3CA—melanoma	3.8e-06	3.55e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CDKN1B—melanoma	3.8e-06	3.55e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MDM2—melanoma	3.79e-06	3.54e-05	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—AKT1—melanoma	3.76e-06	3.52e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PIK3CG—melanoma	3.75e-06	3.5e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TP53—melanoma	3.74e-06	3.49e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ERBB2—melanoma	3.74e-06	3.49e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CASP3—melanoma	3.73e-06	3.48e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL2—melanoma	3.72e-06	3.48e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—IL6—melanoma	3.7e-06	3.46e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PIK3CB—melanoma	3.69e-06	3.44e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—VEGFA—melanoma	3.64e-06	3.4e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCND1—melanoma	3.63e-06	3.39e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PPARG—melanoma	3.62e-06	3.38e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—STAT3—melanoma	3.61e-06	3.37e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NRAS—melanoma	3.6e-06	3.36e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CTNNB1—melanoma	3.59e-06	3.36e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PIK3CD—melanoma	3.58e-06	3.35e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—HRAS—melanoma	3.57e-06	3.34e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CXCL8—melanoma	3.54e-06	3.31e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ALB—melanoma	3.54e-06	3.31e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PIK3CA—melanoma	3.53e-06	3.29e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MMP9—melanoma	3.52e-06	3.29e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—HRAS—melanoma	3.52e-06	3.29e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CDKN1A—melanoma	3.51e-06	3.28e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PTEN—melanoma	3.5e-06	3.27e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PIK3CD—melanoma	3.5e-06	3.27e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NFKB1—melanoma	3.48e-06	3.26e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PIK3CB—melanoma	3.48e-06	3.25e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CDKN1B—melanoma	3.46e-06	3.23e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ALB—melanoma	3.45e-06	3.23e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PTGS2—melanoma	3.45e-06	3.22e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MAPK3—melanoma	3.45e-06	3.22e-05	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—AKT1—melanoma	3.42e-06	3.2e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IL6—melanoma	3.42e-06	3.2e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—AKT1—melanoma	3.42e-06	3.19e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TP53—melanoma	3.41e-06	3.19e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ABCB1—melanoma	3.4e-06	3.18e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CASP3—melanoma	3.39e-06	3.17e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL2—melanoma	3.39e-06	3.16e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—IL6—melanoma	3.37e-06	3.15e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MYC—melanoma	3.35e-06	3.13e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.33e-06	3.11e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCND1—melanoma	3.3e-06	3.08e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PIK3CD—melanoma	3.3e-06	3.08e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MAPK1—melanoma	3.28e-06	3.06e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—EGFR—melanoma	3.28e-06	3.06e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CTNNB1—melanoma	3.27e-06	3.05e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—HRAS—melanoma	3.26e-06	3.05e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ALB—melanoma	3.25e-06	3.04e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MMP9—melanoma	3.2e-06	2.99e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CDKN1A—melanoma	3.19e-06	2.98e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PTEN—melanoma	3.19e-06	2.98e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PIK3CG—melanoma	3.18e-06	2.97e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NFKB1—melanoma	3.17e-06	2.96e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—VEGFA—melanoma	3.16e-06	2.96e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—AKT1—melanoma	3.16e-06	2.95e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—STAT3—melanoma	3.13e-06	2.93e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PRKCA—melanoma	3.13e-06	2.92e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NRAS—melanoma	3.12e-06	2.92e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PIK3CB—melanoma	3.12e-06	2.92e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IL6—melanoma	3.12e-06	2.92e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—AKT1—melanoma	3.11e-06	2.9e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ERCC2—melanoma	3.1e-06	2.9e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—KRAS—melanoma	3.1e-06	2.89e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PTGS2—melanoma	3.1e-06	2.89e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PPARG—melanoma	3.07e-06	2.86e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PIK3CB—melanoma	3.05e-06	2.85e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PTGS2—melanoma	3.02e-06	2.82e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PTEN—melanoma	3.01e-06	2.81e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MAPK3—melanoma	2.99e-06	2.8e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MYC—melanoma	2.91e-06	2.72e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—AKT1—melanoma	2.88e-06	2.69e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—VEGFA—melanoma	2.88e-06	2.69e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PIK3CB—melanoma	2.87e-06	2.68e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—STAT3—melanoma	2.85e-06	2.66e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MAPK1—melanoma	2.85e-06	2.66e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PTGS2—melanoma	2.85e-06	2.66e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—EGFR—melanoma	2.85e-06	2.66e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PIK3CA—melanoma	2.84e-06	2.66e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NRAS—melanoma	2.84e-06	2.66e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PIK3CD—melanoma	2.79e-06	2.61e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ALB—melanoma	2.76e-06	2.58e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TP53—melanoma	2.75e-06	2.57e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MAPK3—melanoma	2.72e-06	2.54e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PTEN—melanoma	2.7e-06	2.52e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—KRAS—melanoma	2.69e-06	2.51e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PIK3CA—melanoma	2.69e-06	2.51e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MYC—melanoma	2.65e-06	2.47e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PTEN—melanoma	2.63e-06	2.46e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HRAS—melanoma	2.63e-06	2.46e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MAPK1—melanoma	2.59e-06	2.42e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—EGFR—melanoma	2.59e-06	2.42e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL6—melanoma	2.52e-06	2.35e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PTEN—melanoma	2.48e-06	2.32e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PIK3CA—melanoma	2.47e-06	2.31e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PIK3CG—melanoma	2.45e-06	2.29e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—KRAS—melanoma	2.45e-06	2.29e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PIK3CB—melanoma	2.43e-06	2.27e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PTGS2—melanoma	2.41e-06	2.25e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TP53—melanoma	2.39e-06	2.23e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PPARG—melanoma	2.37e-06	2.21e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—AKT1—melanoma	2.32e-06	2.17e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—HRAS—melanoma	2.29e-06	2.14e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PIK3CA—melanoma	2.25e-06	2.1e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—AKT1—melanoma	2.2e-06	2.05e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL6—melanoma	2.19e-06	2.04e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TP53—melanoma	2.17e-06	2.03e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PIK3CD—melanoma	2.16e-06	2.01e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ALB—melanoma	2.13e-06	1.99e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PIK3CA—melanoma	2.12e-06	1.98e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PTEN—melanoma	2.1e-06	1.97e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HRAS—melanoma	2.08e-06	1.94e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—AKT1—melanoma	2.02e-06	1.89e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL6—melanoma	1.99e-06	1.86e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PIK3CA—melanoma	1.9e-06	1.78e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PIK3CB—melanoma	1.88e-06	1.76e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PTGS2—melanoma	1.86e-06	1.74e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PIK3CA—melanoma	1.86e-06	1.74e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AKT1—melanoma	1.84e-06	1.72e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PIK3CA—melanoma	1.75e-06	1.64e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—AKT1—melanoma	1.73e-06	1.62e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PTEN—melanoma	1.62e-06	1.52e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—AKT1—melanoma	1.56e-06	1.45e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—AKT1—melanoma	1.52e-06	1.42e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PIK3CA—melanoma	1.48e-06	1.39e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—AKT1—melanoma	1.43e-06	1.34e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—AKT1—melanoma	1.21e-06	1.13e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PIK3CA—melanoma	1.15e-06	1.07e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—AKT1—melanoma	9.35e-07	8.74e-06	CbGpPWpGaD
